Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Roy Davis, Karl Winkler

Premium

Nanosphere has appointed Roy Davis to its board of directors.

Davis was president of J&J Development and vice president of corporate development for all of J&J until his retirement earlier this year. Davis also serves on the boards of Rosetta Genomics and Innosight and is an advisor to the Cleveland Clinic and Wake Forest Baptist Health System.


Karl Winkler has been tapped to oversee Anagnostics' sales and customer support efforts, the St. Valentin, Austria-based firm said this week.

In his new position, Winkler will focus on direct sales to hospitals in Austria, Germany, and the German-speaking areas of Switzerland. He previously held similar positions at Heinen & Loewenstein and Messer Medical Austria, Anagnostics said.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.